|
DK1603570T5
(da)
*
|
2003-02-26 |
2013-12-09 |
Sugen Inc |
Aminoheteroarylforbindelser som proteinkinaseinhibitorer
|
|
CA2556025A1
(en)
*
|
2004-02-23 |
2005-09-09 |
Sugen, Inc. |
Method of treating abnormal cell growth using c-met and m-tor inhibitors
|
|
EP1719763A4
(en)
*
|
2004-02-27 |
2008-01-09 |
Eisai R&D Man Co Ltd |
NEW PYRIDINE DERIVATIVE AND PYRIMIDINE DERIVATIVE (2)
|
|
JP2007531757A
(ja)
*
|
2004-03-30 |
2007-11-08 |
カイロン コーポレイション |
抗癌剤としての置換チオフェン誘導体
|
|
MXPA06011167A
(es)
*
|
2004-04-01 |
2007-01-25 |
Eli Lilli And Company |
Agentes del receptor h3 de histamina, preparacion y usos terapeuticos.
|
|
US8008301B2
(en)
|
2004-04-01 |
2011-08-30 |
Eli Lilly And Company |
Histamine H3 receptor agents, preparation and therapeutic uses
|
|
BRPI0514553A
(pt)
*
|
2004-08-23 |
2008-06-17 |
Lilly Co Eli |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para inibir o receptor de histamina h3 em um mamìfero, para o tratamento de um distúrbio do sistema nervoso, para o tratamento de obesidade e para o tratamento de um distúrbio ou doença, e, uso de um composto ou um sal do mesmo
|
|
MX2007001986A
(es)
*
|
2004-08-26 |
2007-05-10 |
Pfizer |
Compuestos de aminoheteroarilo como inhibidores de proteina quinasa.
|
|
KR20080072105A
(ko)
*
|
2004-08-26 |
2008-08-05 |
화이자 인코포레이티드 |
단백질 티로신 키나제 저해제 중간체의 제조를 위한거울상이성질선택적 생물학적 전환
|
|
CA2577937C
(en)
*
|
2004-08-26 |
2010-12-21 |
Pfizer Inc. |
Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
|
|
JP4242911B2
(ja)
|
2004-08-26 |
2009-03-25 |
ファイザー・インク |
プロテインキナーゼ阻害薬としてのエナンチオピュアなアミノヘテロアリール化合物
|
|
GT200600042A
(es)
*
|
2005-02-10 |
2006-09-27 |
Aventis Pharma Inc |
Compuestos de bis arilo y heteroarilo sustituido como antagonistas selectivos de 5ht2a
|
|
JP2008535790A
(ja)
*
|
2005-03-03 |
2008-09-04 |
サートリス ファーマシューティカルズ， インコーポレイテッド |
サーチュインモジュレーターであるｎ−フェニルベンズアミド誘導体
|
|
BRPI0611439A2
(pt)
*
|
2005-05-13 |
2010-09-08 |
Lexicon Pharmaceuticals Inc |
compostos multicìclicos e métodos para uso dos mesmos
|
|
US8088928B2
(en)
*
|
2005-08-04 |
2012-01-03 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
AU2006278504B2
(en)
|
2005-08-04 |
2013-01-17 |
Sirtris Pharmaceuticals, Inc. |
Imidazopyridine derivatives as sirtuin modulating agents
|
|
US7855289B2
(en)
*
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
US8093401B2
(en)
*
|
2005-08-04 |
2012-01-10 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
WO2007023768A1
(ja)
|
2005-08-24 |
2007-03-01 |
Eisai R & D Management Co., Ltd. |
新規ピリジン誘導体およびピリミジン誘導体（３）
|
|
US7825137B2
(en)
*
|
2005-12-05 |
2010-11-02 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
|
DK1963302T3
(da)
*
|
2005-12-05 |
2013-04-02 |
Pfizer Prod Inc |
Polymorfer af en C-MET/HGFR-inhibitor
|
|
PE20070978A1
(es)
*
|
2006-02-14 |
2007-11-15 |
Novartis Ag |
COMPUESTOS HETEROCICLICOS COMO INHIBIDORES DE FOSFATIDILINOSITOL 3-QUINASAS (PI3Ks)
|
|
RU2008139599A
(ru)
|
2006-03-07 |
2010-04-20 |
Эррэй Биофарма Инк. (Us) |
Гетеробициклические производные пиразола и способы их применения
|
|
WO2007111904A2
(en)
*
|
2006-03-22 |
2007-10-04 |
Vertex Pharmaceuticals Incorporated |
C-met protein kinase inhibitors for the treatment of proliferative disorders
|
|
ES2561406T3
(es)
|
2006-04-14 |
2016-02-26 |
Cell Signaling Technology, Inc. |
Defectos de genes y quinasa ALK mutante en tumores sólidos humanos
|
|
US8168383B2
(en)
|
2006-04-14 |
2012-05-01 |
Cell Signaling Technology, Inc. |
Gene defects and mutant ALK kinase in human solid tumors
|
|
US7601716B2
(en)
|
2006-05-01 |
2009-10-13 |
Cephalon, Inc. |
Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
|
JP2009538317A
(ja)
*
|
2006-05-26 |
2009-11-05 |
バイエル ヘルスケア リミティド ライアビリティ カンパニー |
癌治療のための置換ジアリールウレアを用いた薬物の組み合わせ
|
|
JP2009539878A
(ja)
*
|
2006-06-08 |
2009-11-19 |
アレイ バイオファーマ、インコーポレイテッド |
キノリン化合物および使用方法
|
|
US7683060B2
(en)
|
2006-08-07 |
2010-03-23 |
Incyte Corporation |
Triazolotriazines as kinase inhibitors
|
|
ES2375284T3
(es)
|
2006-08-23 |
2012-02-28 |
Eisai R&D Management Co., Ltd. |
Sal de un derivado de fenoxipiridina, o cristal de la misma, y procedimiento de producción de la misma.
|
|
US7790885B2
(en)
|
2006-08-31 |
2010-09-07 |
Eisai R&D Management Co., Ltd. |
Process for preparing phenoxypyridine derivatives
|
|
WO2008042867A2
(en)
*
|
2006-09-29 |
2008-04-10 |
Emiliem Inc. |
Modulators of multiple kinases
|
|
JP5512274B2
(ja)
|
2006-10-23 |
2014-06-04 |
セファロン、インク． |
ＡＬＫ阻害剤およびｃ−ＭＥＴ阻害剤としての２，４−ジアミノピリミジンの縮合二環式誘導体
|
|
GB0621607D0
(en)
*
|
2006-10-31 |
2006-12-06 |
Chroma Therapeutics Ltd |
Inhibitors of c-Met
|
|
GEP20125658B
(en)
|
2006-11-22 |
2012-10-10 |
Incyte Corp |
Imidazotriazines and imidazo pyrimidines as kinase inhibitors
|
|
ES2396160T3
(es)
|
2006-12-14 |
2013-02-19 |
Bayer Intellectual Property Gmbh |
Derivados de DIHIDROPIRIDINA que utiliza como inhibidores de la proteina quinasa
|
|
WO2008087736A1
(ja)
*
|
2007-01-19 |
2008-07-24 |
Ube Industries, Ltd. |
アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法
|
|
US8551995B2
(en)
*
|
2007-01-19 |
2013-10-08 |
Xcovery Holding Company, Llc |
Kinase inhibitor compounds
|
|
EP2851091B1
(en)
|
2007-04-13 |
2017-12-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer resistant to ERBB therapeutics
|
|
CA2951295C
(en)
*
|
2007-04-16 |
2020-04-28 |
Abbvie Inc. |
7-nonsubstituted indole mcl-1 inhibitors
|
|
US8263585B2
(en)
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
CL2008001822A1
(es)
*
|
2007-06-20 |
2009-03-13 |
Sirtris Pharmaceuticals Inc |
Compuestos derivados de tiazolo[5,4-b]piridina; composicion farmaceutica que comprende a dichos compuestos; y uso del compuesto en el tratamiento de la resistencia a la insulina, sindrome metabolico, diabetes, entre otras.
|
|
BRPI0814423B1
(pt)
|
2007-07-17 |
2022-04-19 |
Plexxikon, Inc |
Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos
|
|
EP2173722B1
(en)
*
|
2007-07-26 |
2012-08-29 |
Novartis AG |
Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
|
|
CN101855342B
(zh)
|
2007-09-13 |
2013-07-10 |
科德克希思公司 |
用于还原苯乙酮的酮还原酶多肽
|
|
EP2215084B1
(en)
*
|
2007-10-23 |
2016-09-28 |
Allergan, Inc. |
Therapeutic substituted lactams
|
|
AU2008319267A1
(en)
*
|
2007-11-01 |
2009-05-07 |
Sirtris Pharmaceuticals, Inc. |
Amide derivatives as sirtuin modulators
|
|
EP2217606A1
(en)
*
|
2007-11-08 |
2010-08-18 |
Sirtris Pharmaceuticals, Inc. |
Solubilized thiazolopyridines
|
|
JP2009132660A
(ja)
|
2007-11-30 |
2009-06-18 |
Eisai R & D Management Co Ltd |
食道癌治療用組成物
|
|
WO2009073224A1
(en)
*
|
2007-12-07 |
2009-06-11 |
Ambit Biosciences Corp. |
Methods of treating certain diseases using pyrimidine derivatives
|
|
US20090227556A1
(en)
*
|
2008-01-31 |
2009-09-10 |
Eisai R&D Management Co., Ltd. |
Receptor tyrosine kinase inhibitors comprising pyridine and pyrimidine derivatives
|
|
JPWO2009096198A1
(ja)
*
|
2008-02-01 |
2011-05-26 |
一般社団法人ファルマＩｐ |
新規ビアリール誘導体
|
|
JP2011511005A
(ja)
*
|
2008-02-04 |
2011-04-07 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
２−アミノピリジン系キナーゼ阻害薬
|
|
AR070317A1
(es)
*
|
2008-02-06 |
2010-03-31 |
Osi Pharm Inc |
Furo (3,2-c) piridina y tieno (3,2-c) piridinas
|
|
EP2248810A4
(en)
*
|
2008-02-18 |
2011-05-25 |
Eisai R&D Man Co Ltd |
METHOD FOR PRODUCING A PHENOXYPYRIDINE DERIVATIVE
|
|
WO2009111644A2
(en)
*
|
2008-03-05 |
2009-09-11 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating pancreatic cancer
|
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
FR2928923B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 2-heteroaryl-6-phenyl-imidazo °1,2-a!pyridines, leur preparation et leur application en therapeutiques
|
|
FR2928924B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives polysubstitues de 6-heteroaryle-imidazo°1,2-a! pyridines, leur preparation et leur application en therapeutique
|
|
FR2928922B1
(fr)
|
2008-03-21 |
2010-04-23 |
Sanofi Aventis |
Derives de 2-aryl-6-phenyl-imidazo°1,2-a!pyridines polysubstitues, leur preparation et leur application en therapeutique
|
|
WO2009151800A1
(en)
*
|
2008-05-07 |
2009-12-17 |
Merck & Co., Inc. |
Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
|
|
CN103936743B
(zh)
|
2008-05-21 |
2018-04-24 |
因西特控股公司 |
2-氟-N-甲基-4-[7-(喹啉-6-基甲基)咪唑并[1,2-b][1,2,4]三嗪-2-基]苯甲酰胺的盐及与其相关的制备方法
|
|
PL2303018T3
(pl)
|
2008-06-19 |
2016-06-30 |
Xcovery Holdings Inc |
Podstawione związki pirydazynokarboksyamidowe jako związki będące inhibitorami kinazy
|
|
JP2012501188A
(ja)
*
|
2008-08-29 |
2012-01-19 |
ジェネンテック， インコーポレイテッド |
Ｖｅｇｆ非依存性腫瘍についての診断薬および治療
|
|
WO2010046780A2
(en)
*
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
JP2012509342A
(ja)
|
2008-11-20 |
2012-04-19 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
置換ピロロ［２，３−ｂ］−ピリジンおよび−ピラジン
|
|
EP2375904B1
(en)
*
|
2008-12-09 |
2014-05-28 |
Merck Sharp & Dohme Corp. |
Biaryl carboxamides
|
|
CN102388054B
(zh)
|
2008-12-19 |
2015-03-04 |
西特里斯药业公司 |
噻唑并吡啶沉默调节蛋白调节剂的化合物
|
|
AU2009327357C1
(en)
|
2008-12-19 |
2017-02-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of ATR kinase
|
|
JP2012102018A
(ja)
*
|
2009-03-03 |
2012-05-31 |
Astellas Pharma Inc |
アミド化合物
|
|
TW201100441A
(en)
|
2009-06-01 |
2011-01-01 |
Osi Pharm Inc |
Amino pyrimidine anticancer compounds
|
|
DE102009056886A1
(de)
|
2009-12-03 |
2011-06-09 |
Bayer Schering Pharma Aktiengesellschaft |
cMet-Inhibitoren zur Behandlung der Endometriose
|
|
EA025304B1
(ru)
|
2010-02-03 |
2016-12-30 |
Инсайт Холдингс Корпорейшн |
ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ
|
|
WO2011138751A2
(en)
*
|
2010-05-04 |
2011-11-10 |
Pfizer Inc. |
Heterocyclic derivatives as alk inhibitors
|
|
MX2012013081A
(es)
|
2010-05-12 |
2013-05-09 |
Vertex Pharma |
Compuestos utiles como inhibidores de cinasa atr.
|
|
JP2013526540A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
WO2011143423A2
(en)
*
|
2010-05-12 |
2011-11-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
AR081039A1
(es)
|
2010-05-14 |
2012-05-30 |
Osi Pharmaceuticals Llc |
Inhibidores biciclicos fusionados de quinasa
|
|
JP2013526570A
(ja)
|
2010-05-14 |
2013-06-24 |
オーエスアイ・ファーマシューティカルズ，エルエルシー |
縮合二環式キナーゼ阻害剤
|
|
US9526648B2
(en)
|
2010-06-13 |
2016-12-27 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US10420665B2
(en)
|
2010-06-13 |
2019-09-24 |
W. L. Gore & Associates, Inc. |
Intragastric device for treating obesity
|
|
US10010439B2
(en)
|
2010-06-13 |
2018-07-03 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
US8628554B2
(en)
|
2010-06-13 |
2014-01-14 |
Virender K. Sharma |
Intragastric device for treating obesity
|
|
CA2802644C
(en)
|
2010-06-25 |
2017-02-21 |
Eisai R & D Management Co., Ltd. |
Antitumor agent using compounds having kinase inhibitory effect in combination
|
|
EP2593434A1
(en)
|
2010-07-16 |
2013-05-22 |
Purdue Pharma LP |
Pyridine compounds as sodium channel blockers
|
|
WO2012042421A1
(en)
|
2010-09-29 |
2012-04-05 |
Pfizer Inc. |
Method of treating abnormal cell growth
|
|
WO2012048259A2
(en)
|
2010-10-08 |
2012-04-12 |
Xcovery Holding Company, Llc |
Substituted pyridazine carboxamide compounds
|
|
PT2646448T
(pt)
|
2010-11-29 |
2017-10-04 |
Osi Pharmaceuticals Llc |
Inibidores macrocíclicos de cinases
|
|
GB201021103D0
(en)
|
2010-12-13 |
2011-01-26 |
Univ Leuven Kath |
New compounds for the treatment of neurodegenerative diseases
|
|
CN103491815B
(zh)
|
2011-02-11 |
2016-01-20 |
巴特马克有限公司 |
吸入器组件
|
|
CA2826892A1
(en)
*
|
2011-02-24 |
2012-08-30 |
Jiangsu Hansoh Pharmaceutical Co., Ltd. |
Phosphorus containing compounds as protein kinase inhibitors
|
|
US9145390B2
(en)
|
2011-03-03 |
2015-09-29 |
Concert Pharmaceuticals, Inc. |
Derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
JO3438B1
(ar)
|
2011-04-13 |
2019-10-20 |
Epizyme Inc |
مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
|
|
WO2012152741A1
(de)
|
2011-05-10 |
2012-11-15 |
Bayer Intellectual Property Gmbh |
Bicyclische (thio)carbonylamidine
|
|
US20140088114A1
(en)
|
2011-05-16 |
2014-03-27 |
OSI Pharmaceuticals ,LLC |
Fused bicyclic kinase inhibitors
|
|
JP2014517079A
(ja)
|
2011-06-22 |
2014-07-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
US9226923B2
(en)
*
|
2011-07-27 |
2016-01-05 |
Nanjing Allgen Pharma Co. Ltd. |
Spirocyclic molecules as protein kinase inhibitors
|
|
MX2014001354A
(es)
|
2011-08-02 |
2014-10-14 |
Pfizer |
Crizotinib para uso en el tratamiento de cancer.
|
|
RS59337B1
(sr)
|
2011-09-30 |
2019-10-31 |
Vertex Pharma |
Postupak za izradu jedinjenja, korisnih kao inhibitori atr kinaze
|
|
SG11201401095YA
(en)
|
2011-09-30 |
2014-04-28 |
Vertex Pharma |
Treating pancreatic cancer and non-small cell lung cancer with atr inhibitors
|
|
EP2822953B9
(en)
|
2012-03-06 |
2017-06-21 |
Pfizer Inc |
Macrocyclic derivatives for the treatment of proliferative diseases
|
|
AU2013203824A1
(en)
|
2012-03-16 |
2013-10-03 |
Purdue Pharma L.P. |
Substituted pyridines and pryimidines as sodium channel blockers
|
|
ES2654670T3
(es)
|
2012-04-05 |
2018-02-14 |
Vertex Pharmaceuticals Incorporated |
Compuestos útiles como inhibidores de la cinasa ATR y terapias de combinación de los mismos
|
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
|
CN104768555B
(zh)
|
2012-04-13 |
2018-10-30 |
Epizyme股份有限公司 |
用于治疗癌症的联合治疗
|
|
CN103387535B
(zh)
*
|
2012-05-10 |
2016-06-01 |
广东东阳光药业有限公司 |
取代的炔基吡啶化合物及其使用方法和用途
|
|
WO2013177092A1
(en)
*
|
2012-05-23 |
2013-11-28 |
Sunshine Lake Pharma Co., Ltd. |
Substituted alkynyl pyridine compounds and methods of use
|
|
GB201211310D0
(en)
*
|
2012-06-26 |
2012-08-08 |
Chroma Therapeutics Ltd |
CSF-1R kinase inhibitors
|
|
AU2013280644B2
(en)
|
2012-06-26 |
2018-08-02 |
Jeffrey A. BACHA |
Methods for treating tyrosine-kinase-inhibitor-resistant malignancies in patients with genetic polymorphisms or AHI1 dysregulations or mutations employing dianhydrogalactitol, diacetyldianhydrogalactitol, dibromodulcitol, or analogs or derivatives thereof
|
|
CN104603620B
(zh)
|
2012-09-24 |
2018-02-23 |
文塔纳医疗系统公司 |
使用间变性淋巴瘤激酶(alk)作为标志物鉴定治疗响应性非小细胞肺癌的方法
|
|
WO2014055756A1
(en)
|
2012-10-04 |
2014-04-10 |
Vertex Pharmaceuticals Incorporated |
Method for measuring atr inhibition mediated increases in dna damage
|
|
US20150299170A1
(en)
*
|
2012-11-21 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
|
|
PT4190786T
(pt)
|
2012-12-07 |
2025-05-29 |
Vertex Pharma |
Compostos úteis como inibidores da quinase atr
|
|
US9714252B2
(en)
|
2012-12-20 |
2017-07-25 |
Purdue Pharma L.P. |
Cyclic sulfonamides as sodium channel blockers
|
|
MX2015004979A
(es)
|
2012-12-21 |
2015-07-17 |
Eisai R&D Man Co Ltd |
Forma amorfa de derivado de quinolina y metodo para su produccion.
|
|
US9708295B2
(en)
*
|
2013-02-02 |
2017-07-18 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Substituted 2-aminopyridine protein kinase inhibitor
|
|
EP2970286A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Inc. |
Fused pyrazolopyrimidine derivatives useful as inhibitors of atr kinase
|
|
JP2016519684A
(ja)
|
2013-04-08 |
2016-07-07 |
デニス エム ブラウン |
準最適に投与された薬物療法の有効性を改善するための及び／又は副作用を低減するための方法および組成物
|
|
SG11201509278XA
(en)
|
2013-05-14 |
2015-12-30 |
Eisai R&D Man Co Ltd |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
|
WO2015034729A1
(en)
*
|
2013-09-05 |
2015-03-12 |
Calitor Sciences, Llc |
Substituted pyridine compounds and methods of use
|
|
US20160214961A1
(en)
*
|
2013-09-10 |
2016-07-28 |
Shilpa Medicare Limited |
Novel salts of crizotinib and their preparation
|
|
RU2550346C2
(ru)
|
2013-09-26 |
2015-05-10 |
Общество с ограниченной ответственностью "Отечественные Фармацевтические Технологии" ООО"ФармТех" |
Новые химические соединения (варианты) и их применение для лечения онкологических заболеваний
|
|
ES2675355T3
(es)
|
2013-09-30 |
2018-07-10 |
Korea Research Institute Of Chemical Technology |
Derivados de triazolopirazina como inhibidores de tirosina cinasa
|
|
US20160280798A1
(en)
|
2013-11-06 |
2016-09-29 |
The United States Of America, As Represented By The Secretary Department Of Health & Human Service |
Alk antibodies, conjugates, and chimeric antigen receptors, and their use
|
|
CA2932757C
(en)
|
2013-12-06 |
2023-10-31 |
Vertex Pharmaceuticals Incorporated |
2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof
|
|
EP3083583B1
(en)
|
2013-12-20 |
2020-11-18 |
Sagimet Biosciences Inc. |
Heterocyclic modulators of lipid synthesis and combinations thereof
|
|
CN103755627B
(zh)
*
|
2014-01-09 |
2016-02-17 |
定陶县友帮化工有限公司 |
2-氨基-3-羟基-5-氯吡啶的合成方法
|
|
US10231965B2
(en)
|
2014-02-20 |
2019-03-19 |
Ignyta, Inc. |
Molecules for administration to ROS1 mutant cancer cells
|
|
EP3122900A1
(en)
|
2014-03-24 |
2017-02-01 |
F. Hoffmann-La Roche AG |
Cancer treatment with c-met antagonists and correlation of the latter with hgf expression
|
|
US10730866B2
(en)
|
2014-04-07 |
2020-08-04 |
Purdue Pharma L.P. |
Indole derivatives and use thereof
|
|
WO2015167825A1
(en)
|
2014-04-29 |
2015-11-05 |
Emory University |
Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
|
|
WO2015172747A1
(en)
*
|
2014-05-16 |
2015-11-19 |
Zhaoyin Wang |
Spirocyclic molecules as mth1 inhibitors
|
|
KR102575125B1
(ko)
|
2014-06-05 |
2023-09-07 |
버텍스 파마슈티칼스 인코포레이티드 |
Atr 키나제의 저해제로서 유용한 2-아미노-6-플루오로-n-[5-플루오로-피리딘-3-일]-피라졸로[1,5-a]피리미딘-3-카복스아미드 화합물의 방사성표지된 유도체, 상기 화합물의 제조 및 이의 다양한 고체 형태
|
|
RU2736219C2
(ru)
|
2014-06-17 |
2020-11-12 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ лечения рака с использованием комбинации ингибиторов снк1 и atr
|
|
WO2016019909A1
(zh)
*
|
2014-08-07 |
2016-02-11 |
江苏豪森药业股份有限公司 |
一种抗癌化合物的新晶型及其制备方法和用途
|
|
WO2016028971A1
(en)
|
2014-08-21 |
2016-02-25 |
Bristol-Myers Squibb Company |
Tied-back benzamide derivatives as potent rock inhibitors
|
|
IL302218B2
(en)
|
2014-08-28 |
2024-10-01 |
Eisai R&D Man Co Ltd |
Methods for manufacturing high-purity lenvatinib and its derivatives
|
|
KR102569226B1
(ko)
*
|
2014-10-13 |
2023-08-22 |
아트린 파마슈티컬스 엘엘씨 |
운동실조 모세혈관확장증 및 Rad3-관련 (ATR) 단백질 키나제 억제제
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
UY36391A
(es)
*
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
|
|
ES2928502T3
(es)
|
2014-11-07 |
2022-11-18 |
Univ Michigan Regents |
Inhibidores de la transcripción génica mediada por el factor de transcripción relacionado con la miocardina y el factor de respuesta sérica (MRTF/SRF) y métodos para el uso de los mismos
|
|
US10085979B2
(en)
|
2014-12-02 |
2018-10-02 |
Ignyta, Inc. |
Combinations for the treatment of neuroblastoma
|
|
US20180000771A1
(en)
|
2015-01-13 |
2018-01-04 |
Kyoto University |
Agent for preventing and/or treating amyotrophic lateral sclerosis
|
|
MA41598A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Constellation Pharmaceuticals Inc |
Composés thérapeutiques de pyridazine et leurs utilisations
|
|
JP6792546B2
(ja)
|
2015-02-25 |
2020-11-25 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
キノリン誘導体の苦味抑制方法
|
|
AU2015384801B2
(en)
|
2015-03-04 |
2022-01-06 |
Eisai R&D Management Co., Ltd. |
Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
|
|
KR20180011843A
(ko)
|
2015-06-11 |
2018-02-02 |
바실리어 파마슈티카 인터내셔널 리미티드 |
유출-펌프 억제제 및 이의 치료적 용도
|
|
EP3311841B1
(en)
|
2015-06-16 |
2021-07-28 |
PRISM BioLab Co., Ltd. |
Anticancer agent
|
|
US10405627B2
(en)
*
|
2015-07-14 |
2019-09-10 |
Michael Charles Boland, III |
Luggage with fold out table
|
|
CN108135894B
(zh)
|
2015-08-20 |
2021-02-19 |
卫材R&D管理有限公司 |
肿瘤治疗剂
|
|
AU2016331955B2
(en)
|
2015-09-30 |
2022-07-21 |
Vertex Pharmaceuticals Incorporated |
Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
WO2017106492A1
(en)
|
2015-12-18 |
2017-06-22 |
Ignyta, Inc. |
Combinations for the treatment of cancer
|
|
WO2017161004A1
(en)
|
2016-03-15 |
2017-09-21 |
University Of South Florida |
PKCδ INHIBITOR FORMULATIONS AND USES THEREOF CROSS-REFERENCE TO RELATED APPLICATIONS
|
|
WO2017180723A1
(en)
|
2016-04-12 |
2017-10-19 |
Atrin Pharmaceuticals LLC |
Ataxia telengiectasia and rad3-related (atr) inhibitors and methods of their use
|
|
US10779980B2
(en)
|
2016-04-27 |
2020-09-22 |
Synerz Medical, Inc. |
Intragastric device for treating obesity
|
|
WO2017201585A1
(en)
*
|
2016-05-26 |
2017-11-30 |
Genea Ip Holdings Pty Ltd |
Modulators of dux4 for regulation of muscle function
|
|
TWI646094B
(zh)
*
|
2016-06-01 |
2019-01-01 |
大陸商貝達藥業股份有限公司 |
Crystal form of inhibitory protein kinase active compound and application thereof
|
|
US11046683B2
(en)
|
2016-12-15 |
2021-06-29 |
Ono Pharmaceutical Co., Ltd. |
Activator of TREK (TWIK RElated K+ channels) channels
|
|
CN106866627B
(zh)
*
|
2017-01-24 |
2021-09-14 |
南方医科大学 |
3-(1-(氨基吡啶氧基)乙基)苯甲酰胺衍生物及其合成方法和应用
|
|
RU2750539C2
(ru)
|
2017-02-08 |
2021-06-29 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Фармацевтическая композиция для лечения опухоли
|
|
AU2018269996A1
(en)
|
2017-05-16 |
2019-11-21 |
Eisai R&D Management Co., Ltd. |
Treatment of hepatocellular carcinoma
|
|
AU2018302178A1
(en)
|
2017-07-18 |
2020-02-13 |
Nuvation Bio Inc. |
1,8-naphthyridinone compounds and uses thereof
|
|
WO2019018584A1
(en)
|
2017-07-18 |
2019-01-24 |
GiraFpharma LLC |
HETEROCYCLIC COMPOUNDS AS ADENOSINE ANTAGONISTS
|
|
JP7203083B2
(ja)
|
2017-07-19 |
2023-01-12 |
イグナイタ インコーポレイテッド |
エントレクチニブを含む薬学的組成物
|
|
EP3697390A1
(en)
|
2017-10-17 |
2020-08-26 |
Ignyta, Inc. |
Pharmaceutical compositions and dosage forms
|
|
CN107794282B
(zh)
*
|
2017-11-20 |
2020-12-25 |
浙江工业大学 |
一种克唑替尼手性中间体的制备方法及菌株
|
|
WO2019154665A1
(en)
*
|
2018-02-07 |
2019-08-15 |
Basf Se |
New pyridine carboxamides
|
|
ES2920702T3
(es)
*
|
2018-03-15 |
2022-08-08 |
Fujian Haixi Pharmaceuticals Co Ltd |
Compuestos de heteroarilo como inhibidores de cinasas
|
|
CN110372664A
(zh)
*
|
2018-04-13 |
2019-10-25 |
华东理工大学 |
选择性jak2抑制剂及其应用
|
|
WO2019206049A1
(en)
*
|
2018-04-25 |
2019-10-31 |
Zhuhai Yufan Biotechnologies Co., Ltd |
Hpk1 inhibitors, preparation method and application thereof
|
|
CN110396087A
(zh)
|
2018-04-25 |
2019-11-01 |
珠海宇繁生物科技有限责任公司 |
Hpk1激酶抑制剂、制备方法及其应用
|
|
CN108947895B
(zh)
*
|
2018-08-22 |
2021-09-24 |
肇庆中彩机电技术研发有限公司 |
一种抗癌活性的化合物
|
|
CA3126704A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Nuvation Bio Inc. |
Heterocyclic compounds as adenosine antagonists
|
|
US11254670B2
(en)
|
2019-01-18 |
2022-02-22 |
Nuvation Bio Inc. |
1,8-naphthyridinone compounds and uses thereof
|
|
KR20210116550A
(ko)
|
2019-01-18 |
2021-09-27 |
누베이션 바이오 인크. |
아데노신 길항제로서의 헤테로시클릭 화합물
|
|
CA3133797A1
(en)
|
2019-03-20 |
2020-09-24 |
Emory University |
Prostaglandin receptor ep2 antagonists, derivatives, and uses related thereto
|
|
CN112533927B
(zh)
|
2019-05-14 |
2025-06-17 |
苏州韬略生物科技股份有限公司 |
可用作激酶抑制剂的被取代的大环
|
|
KR102426921B1
(ko)
|
2019-09-24 |
2022-07-29 |
주식회사 이노보테라퓨틱스 |
헤테로아릴아미도피리딘올 유도체 및 이를 유효성분으로 포함하는 자가면역질환의 예방 또는 치료용 약학적 조성물
|
|
CN112552293A
(zh)
*
|
2019-09-25 |
2021-03-26 |
珠海宇繁生物科技有限责任公司 |
一种protac小分子化合物及其应用
|
|
KR102344185B1
(ko)
*
|
2020-02-26 |
2021-12-27 |
계명대학교 산학협력단 |
신규한 Pim 키나아제 억제제 및 이의 용도
|
|
CN113493437B
(zh)
*
|
2020-04-03 |
2022-07-26 |
中国药科大学 |
含苯并咪唑结构的化合物及其制备方法和用途
|
|
WO2021196655A1
(zh)
*
|
2020-04-03 |
2021-10-07 |
中国药科大学 |
含苯并咪唑结构的化合物及其制备方法与用途
|
|
EP4433445A1
(en)
*
|
2021-11-15 |
2024-09-25 |
The Broad Institute, Inc. |
Compounds, compositions, and methods for inducing antimicrobial intracellular activity and for preventing and treating microbial infections
|
|
JPWO2024009921A1
(enExample)
|
2022-07-04 |
2024-01-11 |
|
|
|
CA3262258A1
(en)
|
2022-08-30 |
2025-06-12 |
Chugai Pharmaceutical Co Ltd |
Combination drug
|